Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nichols

Showing results (681-690 of 973) with videos related to

Pageof 98
Sort By:
Oncogene|February 1, 2019
Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancerJoan Cao, Zhou Zhu, Hui Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative GroupBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Journal of Thoracic Disease|July 19, 2021
Autologous blood patch pleurodesis for prolonged postoperative air leaksIrsa S Hasan, Mark S Allen, Stephen D Cassivi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastasesC Kollmannsberger, C Nichols, M Bamberg, et al.
Cancer|January 19, 2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and youngerBradford S Hoppe, Romaine C Nichols, Randal H Henderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectorsDenise E Sabatino, Amy M Lange, Ekaterina S Altynova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumorsAminah Jatoi, Gamini Soori, Nathan R Foster, et al.
Virus Research|July 20, 2014
The control of anaplastic thyroid carcinoma cell lines by oncolytic poxvirusesNeil Mundi, Sung Um, John Yoo, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.
Journal of Neuroinflammation|July 29, 2019
Systemic TLR2 tolerance enhances central nervous system remyelinationNicholas J Wasko, Meghan Horne Kulak, Debayon Paul, et al.
Pageof 98

Showing results (681-690 of 973) with videos related to

Sort By:
Pageof 98
Oncogene|February 1, 2019
Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancerJoan Cao, Zhou Zhu, Hui Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative GroupBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Journal of Thoracic Disease|July 19, 2021
Autologous blood patch pleurodesis for prolonged postoperative air leaksIrsa S Hasan, Mark S Allen, Stephen D Cassivi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastasesC Kollmannsberger, C Nichols, M Bamberg, et al.
Cancer|January 19, 2012
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and youngerBradford S Hoppe, Romaine C Nichols, Randal H Henderson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectorsDenise E Sabatino, Amy M Lange, Ekaterina S Altynova, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumorsAminah Jatoi, Gamini Soori, Nathan R Foster, et al.
Virus Research|July 20, 2014
The control of anaplastic thyroid carcinoma cell lines by oncolytic poxvirusesNeil Mundi, Sung Um, John Yoo, et al.
Acta Oncologica (Stockholm, Sweden)|December 19, 2012
Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancerLisa McGee, Nancy P Mendenhall, Randal H Henderson, et al.
Journal of Neuroinflammation|July 29, 2019
Systemic TLR2 tolerance enhances central nervous system remyelinationNicholas J Wasko, Meghan Horne Kulak, Debayon Paul, et al.
Pageof 98